For reprint rights or to purchase a copy of your Daily Journal photo, email jeremy@reprintpros.com for prices or call 949-702-5390.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Torts/Personal Injury

Apr. 21, 2025

2 more lawsuits target Depo-Provera over alleged brain tumor risk

Plaintiffs allege Pfizer and Kaiser Permanente failed to adequately warn of the risk, despite emerging studies and international label updates. Attorneys say the cases deserve to be heard individually.

2 more lawsuits target Depo-Provera over alleged brain tumor risk
Mark Chavez of Texas based law firm Matthews & Associates

Two more lawsuits have been filed against Pfizer and Kaiser Permanente in Alameda County claiming negligence in the manufacturing and administering of a contraceptive drug that allegedly causes brain tumors, joining a host of lawsuits across the nation.

The two complaints contain nearly identical claims that the contraceptive medroxyprogesterone acetate, sold under the brand name Depo-Provera, substantially contributed to plaintiffs developing an intracranial meningioma -- a type ...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.